Kunihiko Maeda

971 citations
38 papers · 732 indexed · h-index 14
Topics
Immunotherapy and Immune Responses (10 papers)Lymphoma Diagnosis and Treatment (6 papers)Viral-associated cancers and disorders (4 papers)

In The Last Decade

Kunihiko Maeda

37 papers receiving 717 citations

Peers

Kunihiko Maeda
Comparison fields: 5 of 81
  • Immunology 286
  • Pathology and Forensic Medicine 182
  • Oncology 162
  • Molecular Biology 141
  • Surgery 137
Replace H. Kiener with:
H. Kiener Austria
Yumi Matsumura Japan
Yukiko Iwasaki Japan
Hitoshi Ogasawara Japan
Lourdes Mozo Spain
Fady K. Baddoura United States
Keiji Nakasho Japan
Simone de Haij Netherlands
Naohiko Aozasa Japan
Yasumori Izumi Japan
Kunihiko Maeda relative to H. Kiener Austria H. Kiener's profile →
Citations per field
00.5×1.5×2.4×
H. Kiener · 1×
Citations per year

Countries citing papers authored by Kunihiko Maeda

Since Specialization
Citations

This map shows the geographic impact of Kunihiko Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunihiko Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunihiko Maeda more than expected).

Fields of papers citing papers by Kunihiko Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunihiko Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunihiko Maeda. The network helps show where Kunihiko Maeda may publish in the future.

Co-authorship network of co-authors of Kunihiko Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Kunihiko Maeda. A scholar is included among the top collaborators of Kunihiko Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunihiko Maeda. Kunihiko Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 6
4 6
5 8
6 19
7 24
8 23
9 27
10 4
11 33
12 13
13 1
14 26
15 31
16 12
17 21
18 1
19 2
20 1

About Kunihiko Maeda

Kunihiko Maeda is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology, having authored 38 papers that have together received 732 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Lymphoma Diagnosis and Treatment (6 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Immunology (286 citations), Pathology and Forensic Medicine (182 citations) and Oncology (162 citations). Kunihiko Maeda has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Mitsunori Yamakawa, Naoki Nozaki, Hiroki Takahashi, Osamu Takeuchi, Takanori Arimoto, Seiji Yamaguchi, Yasuchika Takeishi, Isao Kubota, Takuya Miyamoto and Joji Nitobe. Their work appears in journals such as Circulation, Journal of Histochemistry & Cytochemistry and The Journal of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026